大腸鏡檢查瀉藥市場：依藥物類型、通路和地區分類。

Colonoscopy Bowel Preparation Drugs Market, By Drug Type, By Distribution Channel, and By Region

出版日期: 2026年04月27日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

大腸鏡檢查用瀉藥市場預計到 2026 年將達到 24.276 億美元，預計到 2033 年將達到 34.387 億美元。預計從 2026 年到 2033 年，該市場將以 5.1% 的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	24.276億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	5.10%	2033年市場規模預測：	34.387億美元

用於大腸鏡檢查前清潔大腸的藥物和溶液稱為大腸鏡腸道清潔劑。這些口服藥物透過排放糞便來刺激腸道蠕動並排空腸道，從而在檢查過程中清晰地觀察大腸。大腸鏡腸道清潔劑有多種類型，包括等滲劑、低滲透壓劑和複方製劑。等滲劑，例如聚乙二醇 (PEG) 溶液，透過吸引並保留大腸內的水分來發揮作用，促進滲透性排放，從而達到有效的清潔效果。低滲透壓劑具有低滲透壓，可將水分吸入大腸，增加腸道含水量並刺激腸道蠕動。複方製劑通常含有滲透性瀉藥和刺激性瀉藥，結合了兩者的功效，以實現全面的腸道清潔。

市場動態

大腸直腸癌是全球最常見的癌症之一。定期進行大腸鏡檢查對於早期發現和預防至關重要。因此，檢查前需要清潔結腸，導致大腸鏡檢查用腸道清潔劑的需求日益成長。製藥公司正加大研發投入，以提高這些藥物的療效、耐受性和便利性。低劑量和分次給藥等新型劑型正在研發中，旨在提高病患的依從性和滿意度。預計更多便捷的用藥方案將進一步增加大腸鏡檢查用腸道清潔劑的需求。

此外，市場參與者之間的合作與策略聯盟匯集了多家公司的專業知識、資源和網路，從而帶來互惠互利的成果，並推動該領域的進步。例如，2020年1月，歐洲領先的專業製藥公司Norgine BV與南非製藥控股公司Aspen Pharmacare簽署了一項獨家許可和分銷協議，授權Aspen Pharmacare在南部非洲共和國、賴索托王國、史瓦濟蘭、波札那和奈米比亞銷售和推廣其產品「Plenvu」。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數對全球大腸鏡檢查腸道準備市場的主要參與者進行了分析：公司概況、財務表現、產品系列、市場佔有率、分銷策略、主要發展、策略和未來計劃。
本報告提供的見解將使各公司的行銷負責人和經營團隊能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
這份「全球大腸鏡檢查腸道清潔劑市場報告」旨在為該行業的各種相關人員提供服務，包括經銷商、供應商、產品製造商、分銷商、新參與企業和金融分析師。
相關人員可以透過利用分析全球大腸鏡檢查腸道準備市場中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- ASEAN
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第7章競爭情勢

Ferring BV
Bayer AG
Braintree
Bausch Health Companies Inc
Norgine BV

第8章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI3641

Colonoscopy Bowel Preparation Drugs Market is estimated to be valued at USD 2,427.6 Mn in 2026 and is expected to reach USD 3,438.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.1% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 2,427.6 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	5.10%	2033 Value Projection:	USD 3,438.7 Mn

Drugs or solutions used to clean the colon and get it ready for a colonoscopy procedure are known as colonoscopy bowel preparation drugs. To ensure a good vision of the colon during the surgery, these oral medications empty the intestine by causing bowel movements and eliminating faeces. There are several types of colonoscopy bowel preparation drugs available, including isosmotic agents, hyposmotic agents, and combination agents. Isosmotic agents, such as polyethylene glycol (PEG) solutions, work by attracting and retaining water in the colon, resulting in osmotic clearance and effective cleansing. Hyposmotic agents have a lower osmolarity and draw water into the colon, increasing fluid in the bowel and promoting bowel movements. Combination agents often contain a mix of osmotic and stimulant laxatives, providing comprehensive bowel cleansing by combining the benefits of both types.

Market Dynamics

One of the most prevalent cancers worldwide is colorectal cancer. Early detection and prevention depend on routine colonoscopy examinations. As a result, there is a high demand for bowel preparation medications for colonoscopies because they are required to clean the colon before the surgery. Pharmaceutical companies are investing in research and development to improve the effectiveness, tolerability, and convenience of these medications. Efforts are being made to develop new formulations, such as low-volume and split-dose regimens, to enhance patient compliance and satisfaction. The development of more patient-friendly options is expected to further boost the demand for colonoscopy bowel preparation drugs.

Moreover, collaborations and strategic alliances between market players bring together the expertise, resources, and networks of multiple companies, resulting in mutually beneficial outcomes and advancements in the field. For instance, in January 2020, Norgine B.V., a leading European specialist pharmaceutical company entered into an exclusive license and distribution agreement with Aspen Pharmacare, a South African pharmaceutical holding company, for the distribution and commercialization of Plenvu in the Republic of Southern Africa, Lesotho, Eswatini, Botswana, and Namibia.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the global colonoscopy bowel preparation drugs market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Ferring B.V., Bayer AG, Braintree, Bausch Health Companies Inc., and Norgine B.V.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
The global colonoscopy bowel preparation drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global colonoscopy bowel preparation drugs market.

Detailed Segmentation:

Global Colonoscopy Bowel Preparation Drugs, By Drug Type (Revenue, USD Mn, 2021 - 2033)
Isosmotic Agents
- High-volume Polyethylene Glycol Preparations
- Sulfate-free PEG-ELS
- Low-volume PEG Preparations
Hyposmotic Agents
Hyperosmotic Agents
- Oral sodium Sulfate
- Magnesium Citrate
- Sodium Phosphate
Combination Agents
- Sodium Picosulfate/Magnesium Citrate
- Sodium Sulfate and SF-PEG-ELS
Global Colonoscopy Bowel Preparation Drugs, By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
Hospitals Pharmacies
Retail Pharmacies
Others (wholesale distributors, online pharmacies)
Regional Insights (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Company Profiles
Ferring B.V.*
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bayer AG
Braintree
Bausch Health Companies Inc.
Norgine B.V.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Key Highlights
Product launch
PEST Analysis
Regulatory Scenario
Mergers and Acquisitions

4. Global Colonoscopy Bowel Preparation Drugs Market, By Drug Type, 2021 - 2033, (US$ Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Isosmotic Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
  - High-volume Polyethylene Glycol Preparations
  - Sulfate-free PEG-ELS
  - Low-volume PEG Preparations
Hyposmotic Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Hyperosmotic Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
  - Oral sodium Sulfate
  - Magnesium Citrate
  - Sodium Phosphate
Combination Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  - Sodium Picosulfate/Magnesium Citrate
  - Sodium Sulfate and SF-PEG-ELS

5. Global Colonoscopy Bowel Preparation Drugs Market, By Distribution Channel, 2021 - 2033, (US$ Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Others (wholesale distributors, online pharmacies)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)

6. Global Colonoscopy Bowel Preparation Drugs Market, By Region, 2021 - 2033, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - China
  - Japan
  - India
  - Australia
  - ASEAN
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
  - North Africa
  - Central Africa
  - South Africa

7. Competitive Landscape

Ferring B.V.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
Bayer AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
Braintree
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
Bausch Health Companies Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
Norgine B.V.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies